copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
About Us - Genpharm Looking to learn some more about Genpharm? Download our Corporate Profile to know more about what we do, how we do it, and why we do it Download
Contact - Genpharm Genpharm and Apellis Pharmaceuticals Enter in an Exclusive Agreement Dubai, March 1st 2023 Genpharm is pleased to announce it has entered into an exclusive agreement with Apellis Read More
Our History - Genpharm Our founders, Kamel Ghammachi and Karim Smaira, unite their efforts for a bigger purpose: Tackle the unmet needs of people living with rare diseases in the MENA Region – Genpharm is born
Therapeutic Areas - Genpharm Our mission at Genpharm is to partner with biotech pioneers to introduce innovative cures and treatments in the region Currently, our rare diseases portfolio includes product ranging from neuromuscular, metabolic disorders, muscular, lysosomal storage, ophthalmic, and more
Board of Directors - Genpharm Genpharm’s Board is comprised of Senior Executives from several industries including R D, Biotech, Pharmaceutical, Financial Services, and Management Through their Executive Board memberships on several organizations and vast management experience, they provide strategic guidance to Genpharm and its partners in MENAT
argenx and Genpharm Sign Exclusive Commercial and Distribution . . . Genpharm Gains Exclusive Rights to Commercialize Vyvgart ™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis in the Middle East Dubai, United Arab Emirates – January 20th, 2022 Genpharm announced today that it has signed an exclusive partnership with argenx SE under which Genpharm will commercialize VYVGART in the Gulf Region
Genpharm Signs Agreement for Commercialization of ChondroCelect Genpharm Services FZ-LLC, a pharmaceutical marketing and distribution company in Dubai, United Arab Emirates and TiGenix NV (Euronext Brussels: TIG) today announced that they have signed an exclusive agreement for the commercialization of ChondroCelect® in the Middle East region
Message From Our Founders - Genpharm We want to be at the core of this trend in the MENAT region and facilitate access to these innovative therapies Hence, everything we do at Genpharm is focused on supporting people living with rare diseases, their families, and care takers